952 related articles for article (PubMed ID: 27595405)
1. A multifunctional AAV-CRISPR-Cas9 and its host response.
Chew WL; Tabebordbar M; Cheng JK; Mali P; Wu EY; Ng AH; Zhu K; Wagers AJ; Church GM
Nat Methods; 2016 Oct; 13(10):868-74. PubMed ID: 27595405
[TBL] [Abstract][Full Text] [Related]
2. CRISPR/Cas9-mediated genome engineering: an adeno-associated viral (AAV) vector toolbox.
Senís E; Fatouros C; Große S; Wiedtke E; Niopek D; Mueller AK; Börner K; Grimm D
Biotechnol J; 2014 Nov; 9(11):1402-12. PubMed ID: 25186301
[TBL] [Abstract][Full Text] [Related]
3. In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation.
Moreno AM; Fu X; Zhu J; Katrekar D; Shih YV; Marlett J; Cabotaje J; Tat J; Naughton J; Lisowski L; Varghese S; Zhang K; Mali P
Mol Ther; 2018 Jul; 26(7):1818-1827. PubMed ID: 29754775
[TBL] [Abstract][Full Text] [Related]
4. Methods for In Vivo CRISPR/Cas Editing of the Adult Murine Retina.
Hung SS; Li F; Wang JH; King AE; Bui BV; Liu GS; Hewitt AW
Methods Mol Biol; 2018; 1715():113-133. PubMed ID: 29188510
[TBL] [Abstract][Full Text] [Related]
5. Use of AAV Vectors for CRISPR-Mediated In Vivo Genome Editing in the Retina.
Yu W; Wu Z
Methods Mol Biol; 2019; 1950():123-139. PubMed ID: 30783971
[TBL] [Abstract][Full Text] [Related]
6. CRISPR Systems Suitable for Single AAV Vector Delivery.
Stevanovic M; Piotter E; McClements ME; MacLaren RE
Curr Gene Ther; 2022; 22(1):1-14. PubMed ID: 34620062
[TBL] [Abstract][Full Text] [Related]
7. Combining Engineered Nucleases with Adeno-associated Viral Vectors for Therapeutic Gene Editing.
Epstein BE; Schaffer DV
Adv Exp Med Biol; 2017; 1016():29-42. PubMed ID: 29130152
[TBL] [Abstract][Full Text] [Related]
8. CRISPR genome engineering and viral gene delivery: a case of mutual attraction.
Schmidt F; Grimm D
Biotechnol J; 2015 Feb; 10(2):258-72. PubMed ID: 25663455
[TBL] [Abstract][Full Text] [Related]
9. Genome Engineering Using Adeno-associated Virus: Basic and Clinical Research Applications.
Gaj T; Epstein BE; Schaffer DV
Mol Ther; 2016 Mar; 24(3):458-64. PubMed ID: 26373345
[TBL] [Abstract][Full Text] [Related]
10. A pipeline for rapidly generating genetically engineered mouse models of pancreatic cancer using in vivo CRISPR-Cas9-mediated somatic recombination.
Ideno N; Yamaguchi H; Okumura T; Huang J; Brun MJ; Ho ML; Suh J; Gupta S; Maitra A; Ghosh B
Lab Invest; 2019 Jul; 99(8):1233-1244. PubMed ID: 30728464
[TBL] [Abstract][Full Text] [Related]
11. Characterization of Staphylococcus aureus Cas9: a smaller Cas9 for all-in-one adeno-associated virus delivery and paired nickase applications.
Friedland AE; Baral R; Singhal P; Loveluck K; Shen S; Sanchez M; Marco E; Gotta GM; Maeder ML; Kennedy EM; Kornepati AV; Sousa A; Collins MA; Jayaram H; Cullen BR; Bumcrot D
Genome Biol; 2015 Nov; 16():257. PubMed ID: 26596280
[TBL] [Abstract][Full Text] [Related]
12. AAV-CRISPR Gene Editing Is Negated by Pre-existing Immunity to Cas9.
Li A; Tanner MR; Lee CM; Hurley AE; De Giorgi M; Jarrett KE; Davis TH; Doerfler AM; Bao G; Beeton C; Lagor WR
Mol Ther; 2020 Jun; 28(6):1432-1441. PubMed ID: 32348718
[TBL] [Abstract][Full Text] [Related]
13. AAV mediated genome engineering with a bypass coagulation factor alleviates the bleeding phenotype in a murine model of hemophilia B.
Sarangi P; Kumar N; Sambasivan R; Ramalingam S; Amit S; Chandra D; Jayandharan GR
Thromb Res; 2024 Jun; 238():151-160. PubMed ID: 38718473
[TBL] [Abstract][Full Text] [Related]
14. Genome Editing of Murine Liver Hepatocytes by AAV Vector-Mediated Expression of Cas9 In Vivo.
Kashiwakura Y; Ohmori T
Methods Mol Biol; 2023; 2637():195-211. PubMed ID: 36773148
[TBL] [Abstract][Full Text] [Related]
15. CRISPR/Cas9-Based Genome Editing for Disease Modeling and Therapy: Challenges and Opportunities for Nonviral Delivery.
Wang HX; Li M; Lee CM; Chakraborty S; Kim HW; Bao G; Leong KW
Chem Rev; 2017 Aug; 117(15):9874-9906. PubMed ID: 28640612
[TBL] [Abstract][Full Text] [Related]
16. Prevention of acquired sensorineural hearing loss in mice by in vivo Htra2 gene editing.
Gu X; Wang D; Xu Z; Wang J; Guo L; Chai R; Li G; Shu Y; Li H
Genome Biol; 2021 Mar; 22(1):86. PubMed ID: 33752742
[TBL] [Abstract][Full Text] [Related]
17. A truncated reverse transcriptase enhances prime editing by split AAV vectors.
Gao Z; Ravendran S; Mikkelsen NS; Haldrup J; Cai H; Ding X; Paludan SR; Thomsen MK; Mikkelsen JG; Bak RO
Mol Ther; 2022 Sep; 30(9):2942-2951. PubMed ID: 35808824
[TBL] [Abstract][Full Text] [Related]
18. Immune-orthogonal orthologues of AAV capsids and of Cas9 circumvent the immune response to the administration of gene therapy.
Moreno AM; Palmer N; Alemán F; Chen G; Pla A; Jiang N; Leong Chew W; Law M; Mali P
Nat Biomed Eng; 2019 Oct; 3(10):806-816. PubMed ID: 31332341
[TBL] [Abstract][Full Text] [Related]
19. CRISPR-Mediated Integration of Large Gene Cassettes Using AAV Donor Vectors.
Bak RO; Porteus MH
Cell Rep; 2017 Jul; 20(3):750-756. PubMed ID: 28723575
[TBL] [Abstract][Full Text] [Related]
20. CASAAV: A CRISPR-Based Platform for Rapid Dissection of Gene Function In Vivo.
VanDusen NJ; Guo Y; Gu W; Pu WT
Curr Protoc Mol Biol; 2017 Oct; 120():31.11.1-31.11.14. PubMed ID: 28967995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
